Open AccessArticle
Evaluation of Sphingolipids in Wistar Rats Treated to Prolonged and Single Oral Doses of Fumonisin B1
by
Glória M. Direito 1, Adriana P. Almeida 2, Simone Aquino 3, Tatiana Alves dos Reis 4, Claudia Rodrigues Pozzi 5 and Benedito Corrêa 4,*
1
Departamento de Microbiologia e Imunologia, Instituto de Veterinária da Universidade Federal Rural do Rio de Janeiro, CEP 23890.000, Rio de Janeiro, RJ, Brasil
2
Departamento de Bromatologia e Química do Instituto Adolfo Lutz, CEP. 01246-902, São Paulo, Brasil
3
Instituto de Pesquisa Energéticas e Nucleares (IPEN / CNEN - SP), CEP 05508-000, São Paulo, SP, Brasil
4
Departamento de Microbiologia do Instituto de Ciências Biomédicas da Universidade de São Paulo, CEP: 05508-900, São Paulo, SP, Brasil
5
Instituto de Zootecnia, Nova Odessa, 13460-000, SP, Brasil
Cited by 11 | Viewed by 12108
Abstract
The objective of the present study was to evaluate sphingolipid levels (sphingosine-So and sphinganine-Sa) and to compare the Sa/So ratio in liver, serum and urine of Wistar rats after prolonged administration (21 days) of fumonisin B
1 (FB
1). In parallel, the
[...] Read more.
The objective of the present study was to evaluate sphingolipid levels (sphingosine-So and sphinganine-Sa) and to compare the Sa/So ratio in liver, serum and urine of Wistar rats after prolonged administration (21 days) of fumonisin B
1 (FB
1). In parallel, the kinetics of sphingolipid elimination in urine was studied in animals receiving a single dose of FB
1. Prolonged exposure to FB
1 caused an increase in Sa levels in urine, serum and liver. The most marked effect on sphingolipid biosynthesis was observed in animals treated with the highest dose of FB
1. Animals receiving a single dose of FB
1 presented variations in Sa and So levels and in the Sa/So ratio.
Full article